BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/26/2022 10:18:58 AM | Browse: 372 | Download: 1145
 |
Received |
|
2022-06-18 04:07 |
|
Peer-Review Started |
|
2022-06-18 04:09 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-07-14 08:41 |
|
Revised |
|
2022-08-02 05:13 |
|
Second Decision |
|
2022-09-20 03:34 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-09-21 22:20 |
|
Articles in Press |
|
2022-09-21 22:20 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-09-25 12:53 |
|
Publish the Manuscript Online |
|
2022-09-26 10:18 |
| ISSN |
2220-3176 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Clinical significance of anti-nucleocapsid-IgG sero-positivity in SARS-CoV-2 infection in hospitalized patients in North Dakota
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Bakir Dzananovic, Mark Williamson, Casmiar Nwaigwe and Chittaranjan Routray |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Chittaranjan Routray, MD, Clinical Assistant Professor (Honorary), Family Medicine, University of North Dakota School of Medicine and Health Sciences, Minot, ND 58701, United States. routrayc@gmail.com |
| Key Words |
COVID-19; SARS-CoV-2 IgG-N; Anti-nucleocapsid IgG; Cytokines |
| Core Tip |
We intended to study an immunologic marker to predict the need for advanced oxygen supplement system and clinical outcome in order to support our hospital crisis management system during the peak of the pandemic. Our study demonstrated that presence of anti-nucleocapsid-IgG (IgG-N) against severe acute respiratory syndrome coronavirus 2 infection had no impact on the clinical outcome or disease severity in hospitalized coronavirus disease 2019 (COVID-19) patients. We did not find a correlation of statistical significance to use IgG-N as a biomarker to predict clinical outcome in COVID-19 patients admitted to a community hospital in North Dakota. |
| Publish Date |
2022-09-26 10:18 |
| Citation |
Dzananovic B, Williamson M, Nwaigwe C, Routray C. Clinical significance of anti-nucleocapsid-IgG sero-positivity in SARS-CoV-2 infection in hospitalized patients in North Dakota. World J Clin Infect Dis 2022; 12(2): 50-60 |
| URL |
https://www.wjgnet.com/2220-3176/full/v12/i2/50.htm |
| DOI |
https://dx.doi.org/10.5495/wjcid.v12.i2.50 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
